All In Biotech

Drug Trial Radar · NCT05171075

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab vs. Dalteparin on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With GI/GU Associated VTE

Last checked: Nov 19, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 417 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

417

Actual

Start

Sep 27, 2022

Primary completion

Apr 10, 2026

Study completion Apr 10, 2026

Sponsor

Lead sponsor
Anthos Therapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
Novartis Pharmaceuticals
First posted
Dec 28, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) recurrence and bleeding in patients with gastrointestinal (GI)/genitourinary (GU) cancer associated VTE (Magnolia)

Conditions

  • Venous Thromboembolism
  • Deep Venous Thrombosis
  • Pulmonary Embolism

Interventions

  • AbelacimabBiological

    Abelacimab 150 mg

  • DalteparinDrug

    Dalteparin 200 IU/kg/day followed by 150 IU/kg/day

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first event of centrally adjudicated VTE recurrenceTime frame: up to 6 months

Locations

117 sites in 20 countries. Site status is shown where the registry gives one.

  • Washington DC VAMC

    Washington D.C., District of Columbia

  • NorthShore University Health System

    Evanston, Illinois

  • Barnes-Jewish Hospital

    St Louis, Missouri

  • Memorial Sloan Kettering Cancer Center-Middletown

    Middletown, New Jersey

  • Memorial Sloan Kettering Cancer Center-Commack

    Commack, New York

  • Memorial Sloan Kettering Cancer Center-West Harrison

    Harrison, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Weill Cornell Medical College

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • Blacktown Hospital

    Blacktown, New South Wales, Australia

  • Westmead Hospital

    Westmead, New South Wales, Australia

  • Northern Health

    Epping, Victoria, Australia

  • LK Wiener Neustadt

    Neustadt, Austria

  • Medical University of Vienna

    Vienna, Austria

  • University of Calgary

    Calgary, Canada

  • Sault Area Hospital

    Marie, Canada

  • Toronto General Hospital

    Toronto, Canada

  • Hamilton Health Sciences, Juravinski Hospital and Cancer Centre

    Hamilton, Ontario, Canada

  • Ottawa Hospital Research Instituite

    Ottawa, Ontario, Canada

  • Ottawa Hospital Research Instituite

    Ottawa, Ontario, Canada

  • Beijing Shijitan Hosp.

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

  • Jilin Province Tumor Hospital

    Ch’ang-ch’un, China

  • Southern Medical University - Zhujiang Hospital

    Guangdong, China

  • Nanfang Hospital of Southern Medical University

    Guangzhou, China

  • The Sixth Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, China

  • Huizhou Municipal Central Hospital

    Huizhou, China

  • Nanjing First Hospital

    Nanjing, China

  • Nantong Tumor Hospital (Tumor Hospital Affiliated to Nantong University )

    Tongzhou, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, China

  • Union Hospital Tongji Medical College Huazhong University of Science &Technology

    Wuhan, China

  • Hubei Cancer Hospital

    Wuhan, China

  • The Second Hospital of Jiaxing

    Zhejiang, China

  • Masarykuv onkologicky ustav

    Brno, Czechia

  • University Hospital Hradec Kralove

    Hradec Králové, Czechia

  • Onkologická klinika VFN a 1. LF UK

    Prague, Czechia

  • Thomayerova nemocnice

    Prague, Czechia

  • CHU Angers - Hôpital Hôtel Dieu

    Angers, France

  • CHU Clermont Ferrand - Hopital Gabriel Montpied

    Clermont-Ferrand, France

Showing 40 of 117 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.